[go: up one dir, main page]

HK1088213A - Pharmaceutical formulation with an insoluble active agent for pulmonary administration - Google Patents

Pharmaceutical formulation with an insoluble active agent for pulmonary administration Download PDF

Info

Publication number
HK1088213A
HK1088213A HK06105214.3A HK06105214A HK1088213A HK 1088213 A HK1088213 A HK 1088213A HK 06105214 A HK06105214 A HK 06105214A HK 1088213 A HK1088213 A HK 1088213A
Authority
HK
Hong Kong
Prior art keywords
active agent
pharmaceutical formulation
pulmonary administration
insoluble active
insoluble
Prior art date
Application number
HK06105214.3A
Other languages
Chinese (zh)
Other versions
HK1088213B (en
Inventor
Thomas E. Tarara
Jeffry G. Weers
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1088213A publication Critical patent/HK1088213A/en
Publication of HK1088213B publication Critical patent/HK1088213B/en

Links

HK06105214.3A 2002-12-31 2003-12-31 Pharmaceutical formulation with an insoluble active agent for pulmonary administration HK1088213B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US437210P 2002-12-31

Publications (2)

Publication Number Publication Date
HK1088213A true HK1088213A (en) 2006-11-03
HK1088213B HK1088213B (en) 2017-09-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
AU2003282782A1 (en) Pharmaceutically active lipid based formulation of sn38
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU2002257582A1 (en) Pharmaceutical formulation
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
AU4328800A (en) Pharmaceutical formulation
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
AU2003238039A1 (en) Nasal peptide pharmaceutical formulation
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU2003269792A1 (en) Pharmaceutical formulation of olanzapine
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003257982A1 (en) Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
AU2003275006A1 (en) Aerosol drug delivery system employing formulation pre-heating
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
HK1088213A (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
AU3839900A (en) Pharmaceutical formulation
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
AU1388501A (en) Pharmaceutical formulation
GB0201607D0 (en) Formulation for the administration of medicinal substances
WO2002041875A3 (en) Method for producing readily soluble medicament formulations and corresponding formulations